Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.16 USD | -3.64% |
|
-4.50% | -7.23% |
May. 07 | Truist Securities Raises Price Target on OrthoPediatrics to $38 From $35, Maintains Hold Rating | MT |
May. 07 | Transcript : OrthoPediatrics Corp., Q1 2024 Earnings Call, May 07, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.23% | 719M | D+ | ||
-4.40% | 11.52B | A- | ||
-4.86% | 8.3B | C | ||
+43.30% | 5.73B | B+ | ||
-22.44% | 4.69B | C | ||
+7.79% | 3.42B | C- | ||
-17.26% | 2.54B | B- | ||
-13.36% | 2.03B | - | - | |
-16.39% | 1.86B | - | ||
-31.24% | 1.59B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- KIDS Stock
- Ratings OrthoPediatrics Corp.